Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Study: Many Americans Say They Are More Likely to Participate in a Fitness Routine If Given Opportunity to Socialize, Earn Financial Incentives

Published

on

Reading Time: 4 minutes

  • Third-annual UnitedHealthcare Wellness Checkup Survey provides
    insights into people’s knowledge and opinions about various health
    topics, including preferences about employer-sponsored well-being
    programs
  • People trying to improve their health prioritize a healthy diet,
    access to routine medical care, and stopping smoking or reducing
    drinking
  • More than half of survey respondents said they expect to remain
    healthy enough to accomplish everyday activities until 80 or older,
    including 11 percent saying those tasks will “never” be an issue
  • Among employees with access to a well-being program, 57 percent
    said it has helped improve their health; of these, 27 percent said the
    program helped detect a disease or medical condition

MINNETONKA, Minn.–(BUSINESS WIRE)–More than two-thirds of Americans say an incentive of as little as $2
per day would motivate them to devote at least an hour each day toward
improving their health, while nearly 60 percent of people say they would
be more likely to participate in a fitness routine if the program
offered an opportunity to socialize or make friends, according to a new
nationwide survey.

These are some of the findings from the 2019 UnitedHealthcare Wellness
Checkup Survey
, which examines people’s opinions about health topics
and preferences, offering insights to help improve employer-sponsored
well-being or disease-management programs. The survey’s key findings
include:

  • Opportunities to socialize, earn financial incentives appeal to
    many.
    More than half (57 percent) of survey respondents said they
    would be more likely to consistently participate in a fitness routine
    if the regimen provided a social component, either in-person or
    virtually. Among employees with access to a well-being program, 67
    percent said it was important that their significant other or family
    members have the opportunity to participate, too. Across all
    respondents, more than two-thirds (68 percent) said an incentive of as
    little as $2 per day would motivate them to devote at least an hour
    each day toward improving their health.
  • Many people are optimistic about remaining healthy as they age. More
    than half (53 percent) of survey respondents anticipate being able to
    accomplish everyday activities until 80 or older, including 11 percent
    saying those tasks will “never” be an issue. Gen Xers – defined as
    people between 39 and 54 years old – were the most optimistic, with
    nearly three-quarters (74 percent) expecting to maintain their health
    beyond 80, including 15 percent saying health issues will never
    prevent them from accomplishing everyday tasks. However, one
    study
    concluded that 42 percent of Americans 80 or older have
    functional limitations, such as the inability to walk a flight of
    stairs.
  • Healthy diet, access to medical care and stopping smoking top
    priorities.
    Survey respondents considered a healthy diet, such as
    eating fruits and vegetables, as the top priority when trying to
    improve their health, with a mean score of 4.5 (5 being “extremely
    important”). That was followed by access to routine medical care, such
    as an annual physical (4.4); stopping smoking and/or reducing drinking
    (4.4); getting sufficient sleep (4.3); engaging in strength or
    cardiovascular training (4.3); increasing social activity (3.7); and
    improving mindfulness (3.6).
  • Most people underestimate the connection between lifestyle choices
    and chronic conditions.
    About one-fifth (22 percent) of survey
    respondents correctly recognized that 80
    percent or more of the incidence of premature chronic conditions
    ,
    such as heart disease, stroke and diabetes, are generally caused by
    modifiable lifestyle choices, such as risk factors like smoking or
    obesity, as opposed to being caused by genetic factors. More than
    one-third (38 percent) thought between 50 percent and 79 percent of
    premature chronic conditions were caused by lifestyle choices, while
    32 percent said genetics were to blame for more than half of these
    diseases.

“This year employers are expected to invest an average of more than $3.6
million1 on their respective well-being programs, and over 60
percent of employees2 are interested in engaging in these
initiatives. The UnitedHealthcare Wellness Checkup Survey
provides insights that we hope can be helpful to enhance the design and
implementation of well-being programs, which may help improve employees’
health, reduce absenteeism and curb care costs,” said Rebecca Madsen,
UnitedHealthcare chief consumer officer.

Many U.S. companies are investing in wellness programs, with more than
two-thirds (67 percent) of companies planning to expand these
initiatives during the next few years, according to a recent
study
by the National Business Group on Health. A separate
study
published in The American Journal of Cardiology concluded that
one employer’s well-being initiative generated a six-fold return on
investment and reduced health risks for people enrolled in the program.

Many Employees Say Well-being Programs Have Improved Their Health,
Productivity

More than half (57 percent) of people with
access to wellness programs said the initiatives have made a positive
impact on their health. Of these, 82 percent said they were motivated to
pay more attention to their health; 63 percent said they increased
physical activity; 59 percent improved their diet; and 30 percent
reported improved sleep. More than one-quarter (27 percent) said the
program helped detect a disease or medical condition, while 8 percent
said they stopped smoking or using nicotine.

In regard to job performance among those who said the well-being program
made a positive impact on their health, 50 percent said the initiative
helped reduce stress; 49 percent reported improved productivity; and 35
percent said they took fewer sick days. About one-quarter (26 percent)
reported no impact on job performance.

Among employees without access to wellness programs, 70 percent of
respondents said they would be interested in such initiatives if
offered, including 43 percent who are “very interested.” More than
three-quarters (77 percent) of Gen Xers said they wanted access to a
well-being program, more so than any other age group.

About the Survey
The UnitedHealthcare Wellness Checkup
Survey
was conducted April 11-15, 2019, using the Engine Telephone
CARAVAN® survey among a landline and mobile phone probability sample of
1,000 adults ages 18 and older living in the continental United States.
The margin of error was plus or minus 3.1 percent at the 95 percent
confidence level. For complete survey results, click
here
.

About UnitedHealthcare
UnitedHealthcare
is dedicated to helping people live healthier lives and making the
health system work better for everyone by simplifying the health care
experience, meeting consumer health and wellness needs, and sustaining
trusted relationships with care providers. In the United States,
UnitedHealthcare offers the full spectrum of health benefit programs for
individuals, employers, and Medicare and Medicaid beneficiaries, and
contracts directly with more than 1.3 million physicians and care
professionals, and 6,000 hospitals and other care facilities nationwide.
The company also provides health benefits and delivers care to people
through owned and operated health care facilities in South America.
UnitedHealthcare is one of the businesses of UnitedHealth Group (NYSE:
UNH), a diversified health care company. For more information, visit
UnitedHealthcare at www.uhc.com
or follow @UHC on Twitter.

1 National Business Group on Health, 2019
https://www.businessgrouphealth.org/news/nbgh-news/press-releases/press-release-details/?ID=355

2 Rand Corporation, Incentives for Workplace Wellness
Programs, 2015
https://www.rand.org/content/dam/rand/pubs/research_briefs/RB9800/RR9842/RAND_RB9842.pdf

Click
here to subscribe to Mobile Alerts for UnitedHealth Group.

Contacts

Will Shanley
UnitedHealthcare
(714) 204-8005
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Unveils Innovative NO LICK! Terpene Spray for Cannabis Products to Enhance CBD and THC to Achieve the Entourage Effect

Published

on

Continue Reading

Cannabis

Cannabis Concentrate Market to Cross US$2.4 Billion by 2030 amid Rising Medical and Recreational Demand

Published

on

Continue Reading

transfer

IMC to transfer its Oranim Pharmacy shares back to the seller

Published

on

imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller

TORONTO and GLIL YAM, Israel, April 16, 2024 /PRNewswire/ — IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) (the “Company” or “IMC“), a leading medical cannabis company with operations in Israel and Germany, is announcing that, further to the news release dated January 12, 2024, the Company has decided not to make remaining installment payments installments (i.e. NIS 5,873K including interest or 2,154K CAD) by IMC Holdings Ltd., and as such will transfer the 51% shares held by IMC Holdings Ltd back to the  seller.

“With the April 1st cannabis legalization in Germany, we are focusing our resources on the German market, where we expect to see the biggest growth potential,” said Oren Shuster, CEO of IMC. “With both of our core markets, Germany and Israel, currently undergoing rapid evolution, we need to assure that we allocate our resources to the growth opportunities where we expect the best return on investment.”

About IM Cannabis Corp.

IMC (Nasdaq: IMCC) (CSE: IMCC) is an international cannabis company that provides premium cannabis products to medical patients in Israel and Germany, two of the largest medical cannabis markets. The Company has recently exited operations in Canada to pivot its focus and resources to achieve sustainable and profitable growth in its highest value markets, Israel and Germany. The Company leverages a transnational ecosystem powered by a unique data-driven approach and a globally sourced product supply chain. With an unwavering commitment to responsible growth and compliance with the strictest regulatory environments, the Company strives to amplify its commercial and brand power to become a global high-quality cannabis player.

The IMC ecosystem operates in Israel through its commercial relationship with Focus Medical Herbs Ltd., which imports and distributes cannabis to medical patients, leveraging years of proprietary data and patient insights. The Company also operates medical cannabis retail pharmacies, online platforms, distribution centers, and logistical hubs in Israel that enable the safe delivery and quality control of IMC’s products throughout the entire value chain. In Germany, the IMC ecosystem operates through Adjupharm GmbH, where it distributes cannabis to pharmacies for medical cannabis patients. Until recently, the Company also actively operated in Canada through Trichome Financial Corp and its wholly owned subsidiaries, where it cultivated, processed, packaged, and sold premium and ultra-premium cannabis at its own facilities under the WAGNERS and Highland Grow brands for the adult-use market in Canada. The Company has exited operations in Canada and considers these operations discontinued.

Disclaimer for Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements under applicable Canadian and U.S. securities laws (collectively, “forward-looking statements”). All information that addresses activities or developments that we expect to occur in the future are forward-looking statements. Forward-looking statements are often, but not always, identified by the use of words such as “seek”, “anticipate”, “believe”, “plan”, “estimate”, “expect”, “likely” and “intend” and statements that an event or result “may”, “will”, “should”, “could” or “might” occur or be achieved and other similar expressions. Forward-looking statements are based on the estimates and opinions of management on the date the statements are made. In the press release, such forward-looking statements include, but are not limited to,  the occurrence of growth opportunities and the likelihood of growth potential.

Forward-looking statements are based on assumptions that may prove to be incorrect, including but not limited to: the development and introduction of new products; continuing demand for medical and adult-use recreational cannabis in the markets in which the Company operates; the Company’s ability to reach patients through both e-commerce and brick and mortar retail operations; the Company’s ability to maintain and renew or obtain required licenses; the effectiveness of its products for medical cannabis patients and recreational consumers; and the Company’s ability to market its brands and services successfully to its anticipated customers and medical cannabis patients.

The above lists of forward-looking statements and assumptions are not exhaustive. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Actual results may differ materially from those currently anticipated or implied by such forward looking statements due to a number of factors and risks. These include: any failure of the Company to maintain “de facto” control over Focus Medical in accordance with IFRS 10; the failure of the Company to comply with applicable regulatory requirements in a highly regulated industry; unexpected changes in governmental policies and regulations in the jurisdictions in which the Company operates; the effect of the reform on the Company; the Company’s ability to continue to meet the listing requirements of the Canadian Securities Exchange and the NASDAQ Capital Market; any unexpected failure to maintain in good standing or renew its licenses; the ability of the Company and Focus Medical (collectively, the “Group”) to deliver on their sales commitments or growth objectives; the reliance of the Group on third-party supply agreements to provide sufficient quantities of medical cannabis to fulfil the Group’s obligations; the Group’s possible exposure to liability, the perceived level of risk related thereto, and the anticipated results of any litigation or other similar disputes or legal proceedings involving the Group; the impact of increasing competition; any lack of merger and acquisition opportunities; adverse market conditions; the inherent uncertainty of production quantities, qualities and cost estimates and the potential for unexpected costs and expenses; risks of product liability and other safety-related liability from the usage of the Group’s cannabis products; supply chain constraints; reliance on key personnel; the risk of defaulting on existing debt and war, conflict and civil unrest in Eastern Europe and the Middle East

Any forward-looking statement included in this press release is made as of the date of this press release and is based on the beliefs, estimates, expectations and opinions of management on the date such forward-looking information is made.

The Company does not undertake any obligation to update forward-looking statements except as required by applicable securities laws. Investors should not place undue reliance on forward-looking statements. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement.

Company Contacts:

Anna Taranko, Director Investor & Public Relations
IM Cannabis Corp.
+49 157 80554338
[email protected]

Oren Shuster, Chief Executive Officer
IM Cannabis Corp.
[email protected]

Logo – https://mma.prnewswire.com/media/1742228/IM_Cannabis_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/imc-to-transfer-its-oranim-pharmacy-shares-back-to-the-seller-302117984.html

Continue Reading

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania